Patients with multiple myeloma (MM) often relapse over time despite initially achieving a complete response without minimal residual disease following induction treatment, leaving questions about ...

Ukraine's Defence Ministry has approved a new camouflage pattern, MM-25, which will be used for the production of uniform items. Details: The decision was made in June 2025 at the request of Oleksandr ...

Advances in precision therapy with venetoclax in multiple myeloma with t(11;14) and high BCL2 expression: A systematic review. Biological correlates to support a clinical role for tagraxofusp, a novel ...

Milestone survival (MS): An alternative survival endpoint in cancer immunotherapies. This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I. This abstract does not include a full text ...